VALUATION DIAGNOSTIC
Biotech & Contract Research
Specific market analysis for Biotech & Contract Research companies based in Geneva.
Pro-Forma Valuation
Market demand in Geneva for Biotech & Contract Research assets remains strong.
KEY DRIVER
"Basel pharma ecosystem, highest multiples on platform, GLP/GMP regulatory moats, biologics pipeline demand."
Local Multiples (Est.)
7.0 - 10.0x Statutory
Get Your Report
Generate a certified valuation for your Biotech & Contract Research business in Geneva.
Valuation Impact by Size (DACH 2025)
| Size Bucket | Multiple Range | Impact |
|---|---|---|
| Micro (< CHF 1M EBITDA) | 4.3x - 5.8x | -33.3% |
| Small (CHF 1M - 2M EBITDA) | 5.9x - 8.0x | -6.7% |
| Transition (CHF 2M - 5M EBITDA) | 7.2x - 9.8x | +11.1% |
| Lower Mid-Market (CHF 5M - 10M EBITDA) | 9.9x - 13.3x | +33.3% |
| Mid-Market (> CHF 10M EBITDA) | 12.5x - 16.9x | +66.7% |
Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 8.5x
Biotech & Contract Research Market in Geneva
Geneva — known for a robust financial sector, an international business environment — represents a significant market for Biotech & Contract Research companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.
Current EBITDA multiples for Biotech & Contract Research businesses range from 7.0 - 10.0x (statutory) to 9.0 - 14.0x (deal), reflecting a significant arbitrage opportunity. The sector trend is rising, driven by: Basel pharma ecosystem, highest multiples on platform, GLP/GMP regulatory moats, biologics pipeline demand. This positions Geneva as a notable market within the broader Life Sciences & Pharma sector.
Geneva — Economy Snapshot
- Corporate Tax
- 13.9%
- #11/26
- Companies
- 38'500
- 99.1% SME
- Unemployment
- 4.3%
- Median Salary
- CHF 7'850
- /month
- Succession Risk
- 30%
- owners 55+
Why Biotech & Contract Research in Geneva?
Geneva offers a diversified economic base with 38'500 total companies. While not a primary hub for Biotech & Contract Research, the canton's competitive tax environment and skilled workforce create favorable conditions for business operations and valuations.
- Global diplomatic capital with 40+ international organizations creating a unique ecosystem for multilateral business and networking
- World's leading commodity trading hub, handling approximately one-third of global crude oil and grain trades
- Premier private banking and wealth management center with centuries of expertise and CHF trillions under management
Tax Impact on Valuation
At Geneva's effective corporate tax rate of 13.9% (rank #11/26), after-tax EBITDA retention is 86.1%. This directly influences enterprise valuations and buyer economics in the Biotech & Contract Research sector.
FAQ: Biotech & Contract Research in Geneva
How many Biotech & Contract Research companies are in Geneva?
Geneva has 38'500 total companies. Specific Biotech & Contract Research company counts are part of the broader industrial landscape.
What is the corporate tax rate in Geneva?
The effective corporate tax rate in Geneva is 13.9%, ranking #11 among Switzerland's 26 cantons.
What are Biotech & Contract Research valuation multiples in Geneva?
Current statutory EBITDA multiples for Biotech & Contract Research range from 7.0 - 10.0x. Deal-based multiples are 9.0 - 14.0x. These are influenced by Geneva's tax environment and local market conditions.
What is the business succession outlook in Geneva?
Geneva faces a pronounced succession challenge, particularly in its finance, commodity trading, and watchmaking sectors. Many family-owned boutiques and trading houses were founded in the 1970s-1990s, and their principals are now approaching retirement. The highly international ownership base adds complexity, as cross-border succession planning intersects with Swiss, EU, and sometimes Middle Eastern or Asian jurisdictions. The concentration of high-value service businesses amplifies the economic impact of failed successions.
Canton hub: tax data, industry composition, key employers
Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.
Biotech & Contract Research Valuations Across Switzerland
Compare Biotech & Contract Research business valuation benchmarks in other Swiss cantons and cities.
Other Industries in Geneva
Explore valuation data for different sectors based in Geneva.